RIBICHINI, Flavio Luciano
 Distribuzione geografica
Continente #
NA - Nord America 8.358
EU - Europa 6.804
AS - Asia 3.022
AF - Africa 82
SA - Sud America 20
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 2
Totale 18.302
Nazione #
US - Stati Uniti d'America 8.326
CN - Cina 2.191
GB - Regno Unito 2.186
RU - Federazione Russa 813
FR - Francia 720
IE - Irlanda 696
SE - Svezia 609
SG - Singapore 560
IT - Italia 551
FI - Finlandia 470
DE - Germania 411
UA - Ucraina 191
TG - Togo 68
KR - Corea 65
JP - Giappone 41
BE - Belgio 40
VN - Vietnam 28
NL - Olanda 27
TR - Turchia 25
IR - Iran 21
CA - Canada 19
RO - Romania 15
HK - Hong Kong 13
ID - Indonesia 13
AU - Australia 12
IN - India 11
CH - Svizzera 9
IL - Israele 8
AZ - Azerbaigian 7
BR - Brasile 7
CZ - Repubblica Ceca 7
KG - Kirghizistan 7
PA - Panama 6
PE - Perù 6
PL - Polonia 6
PT - Portogallo 6
BG - Bulgaria 5
EG - Egitto 5
MY - Malesia 5
ES - Italia 4
HU - Ungheria 4
LU - Lussemburgo 4
LV - Lettonia 4
NO - Norvegia 4
PH - Filippine 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BY - Bielorussia 3
CO - Colombia 3
DK - Danimarca 3
EE - Estonia 3
JO - Giordania 3
MA - Marocco 3
MX - Messico 3
PK - Pakistan 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TJ - Tagikistan 3
CL - Cile 2
DO - Repubblica Dominicana 2
IS - Islanda 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EU - Europa 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
IQ - Iraq 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NG - Nigeria 1
PY - Paraguay 1
SC - Seychelles 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 18.302
Città #
Southend 2.004
Jacksonville 1.474
Chandler 1.378
Woodbridge 905
Dublin 685
Ann Arbor 533
Ashburn 530
Beijing 405
Houston 403
Singapore 381
New York 345
Lawrence 276
Princeton 276
Wilmington 252
Jinan 207
Nanjing 158
Shenyang 153
Verona 140
Helsinki 139
Hebei 130
Sindelfingen 82
Seattle 78
Tianjin 78
Nanchang 69
Lomé 67
Changsha 64
Milan 62
Haikou 61
Zhengzhou 57
Seoul 56
Washington 54
Taizhou 50
Ningbo 48
Boardman 47
Hangzhou 46
Norwalk 46
Taiyuan 45
Guangzhou 44
Fuzhou 41
Brussels 40
Jiaxing 40
Redwood City 37
Dallas 33
Redmond 32
Fairfield 31
Kent 29
Lanzhou 26
Falls Church 25
Los Angeles 23
Dong Ket 22
Lancaster 19
Tokyo 19
San Francisco 18
Bologna 17
Tappahannock 17
Cambridge 15
Detroit 15
Lappeenranta 15
Munich 15
Moscow 13
Rome 13
Amsterdam 12
Jakarta 12
Edinburgh 11
Romola 11
Santa Clara 11
Hong Kong 10
Toronto 10
Dearborn 9
Dongguan 9
Cedar Knolls 8
Chicago 8
Esslingen am Neckar 8
Zanjan 8
Baku 7
Bishkek 7
Clearwater 7
Frankfurt am Main 7
San Diego 7
Auburn Hills 6
Bari 6
Lima 6
London 6
Saint Louis 6
Venice 6
Warsaw 6
Atlanta 5
Cairo 5
Leawood 5
Melbourne 5
New Delhi 5
Olomouc 5
Ravenna 5
Shanghai 5
Sofia 5
Des Moines 4
Düsseldorf 4
Figline Valdarno 4
Grafing 4
Luxembourg 4
Totale 12.652
Nome #
Clinical outcomes of transcatheter aortic valve implantation: from learning curve to proficiency 491
[The use of activated clotting time (ACT) to optimize heparinization during coronary angioplasty. The nursing personnel of the Hemodynamics Laboratory]. 123
First successful management of aortic valve insufficiency associated with HeartMate II left ventricular assist device support by transfemoral CoreValve implantation: the Columbus's egg? 114
Clinical outcomes of secondary prevention strategies for young patients with cryptogenic stroke and patent foramen ovale 109
Drug-coated balloon: Long-term outcome from a real world three-center experience 101
[Analysis of right electrocardiographic leads in 195 normal subjects]. 98
Hemodynamic predictors of long term survival in end stage cystic fibrosis 96
Short communication: staff dose reduction during coronary angiography using low framing speed. 95
Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial. 93
[Effects on high resolution electrocardiogram of coronary angioplasty in acute myocardial infarct]. 93
17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease. 91
Effects of Aortic Valve Replacement on Left Ventricular Diastolic Function in Patients With Aortic Valve Stenosis 91
Plasma Lipoprotein (a) is not a predictor for restenosis after elective high-pressure coronary stenting. 90
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). 89
On-line quantitative coronary analysis in clinical practice: one step closer to reality? 88
Elective coronary angioplasty with and without surgical standby: clinical and angiographic criteria for the selection of patients. 88
Long-Term (3 Years) Prognosis of Contrast-Induced Acute Kidney Injury After Coronary Angiography 88
On the current epidemic outburst of meta-analytic rage in interventional cardiology. 87
Physiologic Evaluation of Coronary Lesions Using Instantaneous Wave-free Ratio (iFR) in Patients with Severe Aortic Stenosis Undergoing Trans-catheter Aortic Valve Implantation 87
[Elective coronary angioplasty in total absence of heart surgery]. 86
Immediate and long-term clinical performance of bioresorbable vascular scaffolds in a real world population 86
Tpeak-to-Tend/QT is an independent predictor of early ventricular arrhythmias and arrhythmic death in anterior ST elevation myocardial infarction patients 86
Risk stratification in acute coronary syndromes. 86
Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study. 85
Ambulation three hours after elective cardiac catheterisation through the femoral artery. 84
Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans. 83
Early and long-term outcomes after combined percutaneous revascularization in patients with carotid and coronary artery stenoses. 83
[Emergency angioplasty in high-risk acute infarct]. 83
Early aggressive treatment of unstable angina without on-site cardiac surgical facilities: a prospective study of acute and long-term outcome. 83
Coronary Catheterization and Percutaneous Interventions After Transcatheter Aortic Valve Implantation 83
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials. 83
Correlation between Angiographic and Physiologic Evaluation of Coronary Artery Narrowings in Patients With Aortic Valve Stenosis 83
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 82
A model of multi-disciplinary approach to the diagnosis and treatment of young patients with cryptogenic stroke and patent foramen ovale. 82
A Clinical and Angiographic Study of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With Multivessel Coronary Artery Disease: The EXECUTIVE Trial (EXecutive RCT: Evaluating XIENCE V in a Multi Vessel Disease). 82
"Valve in valve" implantation of two self-expandable transcatheter aortic valves in a patient with aortic root aneurysm and massive aortic regurgitation: "a new TAVI option" 82
Veno-Venous Extracorporeal Membrane Oxygenation as a Bridge to and Support for Pulmonary Thromboendarterectomy in Misdiagnosed Chronic Thromboembolic Pulmonary Hypertension 82
iFR-FFR comparison in daily practice: a single-center, prospective, online assessment 82
Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease. 81
In-stent restenosis. 81
Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study 81
Effectiveness and Safety of Transcatheter Aortic Valve Implantation in Patients With Pure Aortic Regurgitation and Advanced Heart Failure 81
Left atrial volume in patients with HER2-positive breast cancer: One step further to predict trastuzumab-related cardiotoxicity 81
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 80
Optimizing the role of transthoracic echocardiography to improve the cardiovascular risk stratification: the dream of subclinical coronary artery disease detection 80
Angiotensin-converting enzyme tissue activity in the diffuse in-stent restenotic plaque. 79
[Radiologic practice and radioprotection in Italian hemodynamic laboratories]. 79
Correlation between intracoronary physiology and myocardial perfusion imaging in patients with severe aortic stenosis 79
Clinical Implications of Distal Vessel Stenosis After Successful Coronary Chronic Total Occlusion Recanalization 79
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale. 78
Angiographic follow-up after coronary implantation of the Multilink stent: a prospective observation. 78
[Primary angioplasty in acute inferior myocardial infarct with anterior ST-segment depression: the long-term follow-up]. 78
[Heart catheterization via the femoral artery with a 4 French and mobilization at 2 hours]. 78
[Quality assurance and cost control in invasive and interventional cardiology]. 78
Long-term follow-up after trans-catheter tricuspid valve-in-valve replacement with balloon-expandable aortic valves 78
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants 77
Functional mitral regurgitation: are we treating the real target? 77
Coronary physiology in patients with severe aortic stenosis: Comparison between fractional flow reserve and instantaneous wave-free ratio 77
Intracoronary beta-irradiation prevents excessive in-stent neointimal proliferation in de novo lesions of patients with high plasma ACE levels. The BetAce randomized trial. 77
Plasma Activity and Insertion/Deletion Plymorphism of Angiotensin-Converting Enzyme: A Major Risk Factor and a Marker of Risk for Coronary Stent Restenosis. 76
Percutaneous transcatheter balloon valvuloplasty for severe tricuspid valve stenosis in Ebstein's anomaly. 76
Clinical outcome after endovascular, surgical or hybrid revascularisation in patients with combined carotid and coronary artery disease: the Finalised Research In ENDovascular Strategies Study Group (FRIENDS). 76
Prognosis and disease progression in patients under 50 years old undergoing PCI: the CRAGS (Coronary aRtery diseAse in younG adultS) study 76
Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial 76
Angiotensin antagonism in coronary artery disease: results after coronary revascularisation. 75
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. 75
Unsuspected infrahepatic interruption of inferior vena cava associated with floppy mitral valve, mitral valve prolapse, and severe mitral regurgitation. 75
[Diagnostic hemodynamics in day-hospital care]. 75
Observations from a real-time, iFR-FFR "hybrid approach" in patients with severe aortic stenosis and coronary artery disease undergoing TAVI 75
Cellular immunostaining of angiotensin-converting enzyme in human coronary atherosclerotic plaques. 74
Acute myocardial infarction: reperfusion treatment. 74
Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty. 74
Prevalence of patients with severely reduced aortic valve area and low gradient despite a preserved ejection fraction. Results from a cath-lab data base. 74
Functional Assessment of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation Influence of Pressure Overload on the Evaluation of Lesions Severity 74
The Activated Clotting Time Paradox: Relationship Between Activated Clotting Time and Occlusion of the Radial Artery When Used as Vascular Access for Percutaneous Coronary Procedures 74
Comparison of frequency of insulin resistance after coronary stenting in patients with type 2 diabetes mellitus with versus without coronary restenosis 73
Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries 73
Accuracy of Micro-Computed Tomography in Post-mortem Evaluation of Fetal Congenital Heart Disease. Comparison Between Post-mortem Micro-CT and Conventional Autopsy 73
Association study of the I/D polymorphism and plasma angiotensin-converting enzyme (ACE) as risk factors for stent restenosis 72
Left internal mammary artery graft stenosis. Atherosclerosis, spasm or kinking? 72
The diagnosis of coronary artery disease in hypertensive patients with chest pain and complete left bundle branch block: utility of adenosine Tc-99m tetrofosmin SPECT. 72
Coronary stenting after unsuccessful emergency angioplasty in acute myocardial infarction: results in a series of consecutive patients. 72
[Invasive cardiological diagnosis in an ambulatory regimen of transported inpatients]. 72
Dyspnea following thoracostomy closure after right pneumonectomy: An uncommon echocardiographic diagnosis and therapeutic approach 72
Early functional and structural changes of the left atrium in a patient with trastuzumab: related cardiotoxicity 72
Transfemoral Edwards-Novaflex valve implantation in a patient with aorto-iliac endoprosthesis and severely tortuous bilateral external iliac arteries-"Railing track". 71
Physiological Versus Angiographic Guidance for Myocardial Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation 71
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial. 70
Concomitant myocardial infarction in identical twins with similar coronary lesions. 70
Is TAVI superior to surgery in high-risk patients? Insight into the concept of individual risk assessment 70
Transcatheter valve-in-mitral homograft in tricuspid position: first-in-man report 70
Contrast-Induced Acute Kidney Injury in Patients Undergoing TAVI Compared With Coronary Interventions 70
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease 69
Drug eluting balloon for the treatment of patients with coronary artery disease: Current perspectives 69
Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease 69
First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithm 69
Use of Gianturco-Roubin stents for treating abrupt occlusion of unprotected left main stem during elective PTCA. 68
Management of combined severe carotid and coronary artery disease. 68
Glucocorticoids in the prevention of restenosis after coronary angioplasty: therapeutic potential. 68
Steroid-eluting stents in patients with acute coronary syndromes. Angiographic results of DESIRE: Dexamethasone-Eluting Stent Italian REgistry. 67
Totale 8.416
Categoria #
all - tutte 79.077
article - articoli 79.077
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.154


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.657 0 0 0 179 164 344 136 149 84 213 108 280
2020/20212.347 264 409 125 345 300 267 28 130 127 62 245 45
2021/20221.722 171 350 15 103 80 47 25 107 67 71 185 501
2022/20234.328 319 454 453 647 351 1.046 91 286 480 22 110 69
2023/20242.876 87 198 277 306 315 600 136 214 23 172 376 172
2024/20251.520 371 414 239 496 0 0 0 0 0 0 0 0
Totale 18.604